| Source Date | Board Meeting Date | Details |
|
25-Mar-2025
|
27-May-2025
|
Audited Results
|
|
08-Jan-2025
|
31-Jan-2025
|
Quarterly Results
|
|
10-Oct-2024
|
12-Nov-2024
|
Quarterly Results
|
|
27-Jun-2024
|
02-Aug-2024
|
Quarterly Results
|
|
01-Apr-2024
|
28-May-2024
|
Audited Results
|
|
16-Feb-2024
|
21-Feb-2024
|
Inter alia, to discuss the management recommendation to not proceed with the approval for Qualified Institutional Placement (QIP) received from shareholders on November 30, 2023.
|
|
27-Dec-2023
|
02-Feb-2024
|
Quarterly Results
|
|
25-Oct-2023
|
08-Nov-2023
|
Quarterly Results (Revised)
|
|
18-Oct-2023
|
26-Oct-2023
|
Quarterly Results
|
|
06-Oct-2023
|
11-Oct-2023
|
Inter alia, to consider and evaluate proposal for raising of funds by the Company, by way of inter alio, issue of equity shares or any other equity linked instruments or securities including convertible preference shares/ fully or partly convertible debentures or by way of a composite issue of non-convertible debentures and warrants entitling the warrant holder(s) to apply for equity shares, or any other eligible securities through inter alio, a private placement (including one or more qualified institutions placements) or further public issue of equity/ debt securities, preferential issue or a rights issue or through any other permissible mode under applicable laws and/ or combination thereof, as may be considered appropriate, subject to such statutory/regulatory/other approvals as may be required, including the approval of the members, to seek their consent for such fund raising and to approve ancillary actions for such fund raising. The Board, would further convene an Extra-ordinary General Meeting or postal ballot to obtain the approval of shareholders for the above proposal, once approved by the Board.
|